物质信息

ID:318

名称和标识
IUPAC传统名
nitric oxide
IUPAC标准名
nitroso
别名
Nitric Oxide
商标名
NONitric oxide trimerNitrogen monooxideNitrogen oxideAmidogen, oxo-Nitrosyl radicalRCRA waste number P076nitrogen protoxideMononitrogen monoxideNitrogen monoxideNitric oxide 10% by volume or moreINOmaxNMO
数据登录号
PubChem SID
PubChem CID
化合物性质
理化性质
溶解度
9.49E+004 mg/L
疏水性(logP)
0
描述信息
Drug Groups
approved
Description
Nitric oxide or Nitrogen monoxide is a chemical compound with chemical formula NO. This gas is an important signaling molecule in the body of mammals including humans and is an extremely important intermediate in the chemical industry. It is also a toxic air pollutant produced by automobile engines and power plants.

Nitric oxide (NO) should not be confused with nitrous oxide (N2O), a general anaesthetic, or with nitrogen dioxide (NO2) which is another poisonous air pollutant.

The nitric oxide molecule is a free radical, which is relevant to understanding its high reactivity. It reacts with the ozone in air to form nitrogen dioxide, signalled by the appearance of the reddish-brown color.
Indication
For the treatment of term and near-term (>34 weeks) neonates with hypoxic respiratory failure
Pharmacology
Persistent pulmonary hypertension of the newborn (PPHN) occurs as a primary developmental defect or as a condition secondary to other diseases such as meconium aspiration syndrome (MAS), pneumonia, sepsis, hyaline membrane disease, congenital diaphragmatic hernia (CDH), and pulmonary hypoplasia. In these states, pulmonary vascular resistance (PVR) is high, which results in hypoxemia secondary to right-to-left shunting of blood through the patent ductus arteriosus and foramen ovale. In neonates with PPHN, Nitric oxide improves oxygenation (as indicated by significant increases in PaO2). Nitric oxide appears to increase the partial pressure of arterial oxygen (PaO2) by dilating pulmonary vessels in better entilated areas of the lung, redistributing pulmonary blood flow away from lung regions with low ventilation/perfusion (V/Q) ratios toward regions with normal ratios.
Affected Organisms
Humans and other mammals
Biotransformation
via pulmonary capillary bed
Absorption
Nitric oxide is absorbed systemically after inhalation.
Half Life
2–6 seconds
Elimination
Nitrate has been identified as the predominant nitric oxide metabolite excreted in the urine, accounting for >70% of the nitric oxide dose inhaled.
References
• Pacher P, Beckman JS, Liaudet L: Nitric oxide and peroxynitrite in health and disease. Physiol Rev. 2007 Jan;87(1):315-424. [Pubmed]
External Links
分子图谱
暂无数据
点击上传数据
参考文献
• Pacher P, Beckman JS, Liaudet L: Nitric oxide and peroxynitrite in health and disease. Physiol Rev. 2007 Jan;87(1):315-424. Pubmed